Want to see AAPG full AI Analyst Report?
Total Valuation
Ascentage Pharma Group International Unsponsored ADR has a market cap or net worth of $1.57B. The enterprise value is $1.67K.
Market Cap$1.57B
Enterprise Value$1.67K
Share Statistics
Ascentage Pharma Group International Unsponsored ADR has 93,402,810 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding93,402,810
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ascentage Pharma Group International Unsponsored ADR’s return on equity (ROE) is -0.91 and return on invested capital (ROIC) is -33.26%.
Return on Equity (ROE)-0.91
Return on Assets (ROA)-0.30
Return on Invested Capital (ROIC)-33.26%
Return on Capital Employed (ROCE)-0.51
Revenue Per Employee728.13K
Profits Per Employee-1.61M
Employee Count767
Asset Turnover0.14
Inventory Turnover4.60
Valuation Ratios
The current PE Ratio of Ascentage Pharma Group International Unsponsored ADR is ―. Ascentage Pharma Group International Unsponsored ADR’s PEG ratio is -0.09.
PE Ratio―
PS Ratio29.25
PB Ratio12.33
Price to Fair Value12.33
Price to FCF-13.59
Price to Operating Cash Flow-7.67
PEG Ratio-0.09
Income Statement
In the last 12 months, Ascentage Pharma Group International Unsponsored ADR had revenue of 558.48M and earned -1.21B in profits. Earnings per share was -13.56.
Revenue558.48M
Gross Profit426.75M
Operating Income-1.18B
Pretax Income-1.20B
Net Income-1.21B
EBITDA-1.10B
Earnings Per Share (EPS)-13.56
Cash Flow
In the last 12 months, operating cash flow was -1.38B and capital expenditures -19.48M, giving a free cash flow of -1.40B billion.
Operating Cash Flow-1.38B
Free Cash Flow-1.40B
Free Cash Flow per Share-14.99
Dividends & Yields
Ascentage Pharma Group International Unsponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.91
52-Week Price Change-58.91%
50-Day Moving Average37.24
200-Day Moving Average―
Relative Strength Index (RSI)34.89
Average Volume (3m)8.43K
Important Dates
Ascentage Pharma Group International Unsponsored ADR upcoming earnings date is Mar 31, 2027, TBA (Confirmed).
Last Earnings DateAug 19, 2026
Next Earnings DateMar 31, 2027
Ex-Dividend Date―
Financial Position
Ascentage Pharma Group International Unsponsored ADR as a current ratio of 1.79, with Debt / Equity ratio of 376.46%
Current Ratio1.79
Quick Ratio1.77
Debt to Market Cap0.12
Net Debt to EBITDA0.45
Interest Coverage Ratio-22.42
Taxes
In the past 12 months, Ascentage Pharma Group International Unsponsored ADR has paid 6.75M in taxes.
Income Tax6.75M
Effective Tax Rate>-0.01
Enterprise Valuation
Ascentage Pharma Group International Unsponsored ADR EV to EBITDA ratio is -14.47, with an EV/FCF ratio of -13.19.
EV to Sales28.37
EV to EBITDA-14.47
EV to Free Cash Flow-13.19
EV to Operating Cash Flow-13.50
Balance Sheet
Ascentage Pharma Group International Unsponsored ADR has $1.90B in cash and marketable securities with $2.10B in debt, giving a net cash position of -$199.06M billion.
Cash & Marketable Securities$1.90B
Total Debt$2.10B
Net Cash-$199.06M
Net Cash Per Share-$2.13
Tangible Book Value Per Share$13.98
Margins
Gross margin is 81.56%, with operating margin of -211.14%, and net profit margin of -216.47%.
Gross Margin81.56%
Operating Margin-211.14%
Pretax Margin-215.29%
Net Profit Margin-216.47%
EBITDA Margin-196.08%
EBIT Margin-211.14%
Analyst Forecast
The average price target for Ascentage Pharma Group International Unsponsored ADR is $46.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$46.50
Price Target Upside175.15% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast69.80%
EPS Growth Forecast-12.46%